- Home
- PRGS vs PLSE Comparison
PRGS vs PLSE Comparison
Compare PRGS & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRGS | PLSE |
|---|---|---|
| Founded | 1981 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PRGS | PLSE |
|---|---|---|
| Price | $37.65 | $18.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $66.33 | $22.00 |
| AVG Volume (30 Days) | ★ 1.1M | 406.8K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.79 | N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | ★ $397,572,000.00 | N/A |
| Revenue This Year | $3.60 | $912.86 |
| Revenue Next Year | $1.28 | $259.66 |
| P/E Ratio | $23.78 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $34.57 | $12.56 |
| 52 Week High | $65.50 | $26.30 |
Technical Indicators
Market Signals| Indicator | PRGS | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 41.47 | 50.94 |
| Support Level | $35.52 | $13.75 |
| Resistance Level | $44.09 | $20.40 |
| Average True Range (ATR) | 2.25 | 1.27 |
| MACD | -0.08 | -0.47 |
| Stochastic Oscillator | 29.29 | 20.01 |
Price Performance
Historical ComparisonAbout PRGS Progress Software Corporation (DE)
Progress Software Corp provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. The following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include the United States, Canada, EMEA, Latin America, and Asia Pacific.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.